Cargando…

Effect of Cost and Formulation on Persistence and Adherence to Initial Metformin Therapy for Type 2 Diabetes

Detalles Bibliográficos
Autores principales:	Flory, James H., Mushlin, Alvin I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2020
Materias:	e-Letters: Observations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245354/ https://www.ncbi.nlm.nih.gov/pubmed/32253222 http://dx.doi.org/10.2337/dc19-2426

Ejemplares similares

Identifying prevalence and risk factors for metformin non-persistence: a retrospective cohort study using an electronic health record
por: Flory, James H, et al.
Publicado: (2018)

Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial
por: Crowley, Matthew J., et al.
Publicado: (2020)

Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes
por: Zaccardi, Francesco, et al.
Publicado: (2021)

Overcoming barriers to the use of metformin: patient and provider perspectives
por: Flory, James H, et al.
Publicado: (2019)

Virtual Look AHEAD Program: Initial Support for a Partly Virtualized Intensive Lifestyle Intervention in Type 2 Diabetes
por: Williams, Geoffrey C., et al.
Publicado: (2014)

Incidence of Type 2 Diabetes in Patients With Chronic Hepatitis C Receiving Interferon-Based Therapy
por: Tsai, Ming-Chieh, et al.
Publicado: (2020)

Burden of Diabetic Peripheral Neuropathy in Pima Indians With Type 2 Diabetes
por: Jaiswal, Mamta, et al.
Publicado: (2016)

Images From the Exeter Archival Diabetes Biobank Now Accessible via Pancreatlas
por: Morgan, Noel G., et al.
Publicado: (2022)

Burden of Complications in U.S. Adults With Young-Onset Type 2 or Type 1 Diabetes
por: Fang, Michael, et al.
Publicado: (2020)

PCSK9 Is Increased in Youth With Type 1 Diabetes
por: Levenson, Amy E., et al.
Publicado: (2017)

Improving the Prediction of Type 1 Diabetes Across Ancestries
por: Kaddis, John S., et al.
Publicado: (2022)

Out of Pocket Diabetes-Related Medical Expenses for Adolescents and Young Adults With Type 1 Diabetes: The SEARCH for Diabetes in Youth Study
por: Merjaneh, Lina, et al.
Publicado: (2019)

Predictive Value of Admission Hemoglobin A(1c) on Inpatient Glycemic Control and Response to Insulin Therapy in Medicine and Surgery Patients With Type 2 Diabetes
por: Pasquel, Francisco J., et al.
Publicado: (2015)

Evaluation of the Clinical Impact of Dapagliflozin Discontinuation as Adjunctive Therapy for Patients With Type 1 Diabetes After Indication Withdrawal: A Two-Center Retrospective Study
por: Martínez-Montoro, José Ignacio, et al.
Publicado: (2023)

Dietary Phosphatidylcholine Intake and Type 2 Diabetes in Men and Women
por: Li, Yanping, et al.
Publicado: (2015)

Early Worsening of Diabetic Nephropathy in Type 2 Diabetes After Rapid Improvement in Chronic Severe Hyperglycemia
por: Cundy, Tim, et al.
Publicado: (2021)

Changes in Management of Type 2 Diabetes Before and After Severe Hypoglycemia
por: Vijayakumar, Pavithra, et al.
Publicado: (2020)

Reporting of Immune Checkpoint Inhibitor Therapy–Associated Diabetes, 2015–2019
por: Liu, Jiaqing, et al.
Publicado: (2020)

Simultaneous Consideration of HbA(1c) and Insulin Resistance Improves Risk Assessment in White Individuals at Increased Risk for Future Type 2 Diabetes
por: Meigs, James B., et al.
Publicado: (2020)

Cardiovascular Disease Protection in Long-Duration Type 1 Diabetes and Sex Differences
por: He, Zhiheng H., et al.
Publicado: (2015)

Effect of Lipohypertrophy on Accuracy of Continuous Glucose Monitoring in Patients With Type 1 Diabetes
por: DeSalvo, Daniel J., et al.
Publicado: (2015)

Continuous Glucose Monitoring in Patients With Type 1 Diabetes Using Insulin Injections
por: Foster, Nicole C., et al.
Publicado: (2016)

Commuter Cycling and Risk of Type 2 Diabetes: A Cohort Study in Japan
por: Kuwahara, Keisuke, et al.
Publicado: (2022)

Intensive Glycemic Control Improves Long-term Renal Outcomes in Type 2 Diabetes in the Veterans Affairs Diabetes Trial (VADT)
por: Agrawal, Lily, et al.
Publicado: (2019)

Inequity in Racial-Ethnic Representation in Randomized Controlled Trials of Diabetes Technologies in Type 1 Diabetes: Critical Need for New Standards
por: Akturk, Halis K., et al.
Publicado: (2021)

Gastric Bypass Surgery in Severely Obese Women With Type 1 Diabetes: Anthropometric and Cardiometabolic Effects at 1 and 5 Years Postsurgery
por: Middelbeek, Roeland J.W., et al.
Publicado: (2015)

Two- and Four-Hour Tests Differ in Capture of C-Peptide Responses to a Mixed Meal in Type 1 Diabetes
por: Boyle, Karen D., et al.
Publicado: (2016)

Did the COVID-19 Lockdown Affect the Incidence of Pediatric Type 1 Diabetes in Germany?
por: Tittel, Sascha René, et al.
Publicado: (2020)

Exposure to Type 2 Diabetes Provokes Mitochondrial Impairment in Apparently Healthy Human Hearts
por: Zweck, Elric, et al.
Publicado: (2021)

Subjects With Extreme-Duration Type 1 Diabetes Exhibit No Structural or Functional Abnormality on Cardiac MRI
por: Asghar, Omar, et al.
Publicado: (2016)

Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 Diabetes
por: Bjornstad, Petter, et al.
Publicado: (2018)

Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO Study
por: Wargny, Matthieu, et al.
Publicado: (2020)

Survival After Islet Transplantation in Subjects With Type 1 Diabetes: Twenty-Year Follow-Up
por: Lemos, Joana R.N., et al.
Publicado: (2021)

Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes
por: Imafuku, Tadashi, et al.
Publicado: (2021)

New-Onset Fulminant Type 1 Diabetes After SARS-CoV-2 Infection
por: Pan, Yunfei, et al.
Publicado: (2023)

Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries
por: Lyons, Sarah K., et al.
Publicado: (2017)

The Relationship of Serum Soluble Receptor for Advanced Glycation End Products (sRAGE) and Carboxymethyl Lysine (CML) to the Incidence of Diabetic Nephropathy in Persons With Type 1 Diabetes
por: Klein, Ronald, et al.
Publicado: (2017)

Exenatide Improves HDL Particle Counts and Size Distribution in Patients With Long-standing Type 1 Diabetes
por: Gourgari, Evgenia A., et al.
Publicado: (2017)

Lessons From Continuous Glucose Monitoring in Youth With Pre–Type 1 Diabetes, Obesity, and Cystic Fibrosis
por: Chan, Christine L., et al.
Publicado: (2020)

Primary Care Health Care Use for Patients With Type 2 Diabetes During the COVID-19 Pandemic
por: Misra-Hebert, Anita D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o4aj7c3glaea1rjtpvm91bhb1j